A detailed history of Headlands Technologies LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 19,671 shares of CDNA stock, worth $405,419. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,671
Holding current value
$405,419
% of portfolio
0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$14.41 - $33.99 $283,459 - $668,617
19,671 New
19,671 $614,000
Q1 2024

May 07, 2024

SELL
$7.96 - $12.37 $19,390 - $30,133
-2,436 Reduced 57.92%
1,770 $18,000
Q4 2023

Feb 02, 2024

BUY
$4.9 - $12.86 $20,609 - $54,089
4,206 New
4,206 $50,000
Q2 2023

Aug 03, 2023

BUY
$7.61 - $9.46 $42,303 - $52,588
5,559 New
5,559 $47,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.1B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.